Terms of Use
Last updated: 9 Feb 2026
By clicking “I Agree”, creating an account, accessing or using the Product, or otherwise indicating acceptance, you agree to be bound by these Terms and Conditions (“Terms”), which govern your access to and use of the Product provided by Brow.si Mobile Ltd. (“Company”), and you represent that you have the authority to bind the entity on whose behalf you are accessing or using the Product (“Evaluator” or “you”). If you do not agree to these Terms, do not access or use the Product. The “Effective Date” is the date you first access or use the Product.
1. License. Subject to Evaluator’s full compliance with the terms and conditions hereof, Company hereby grants to Evaluator a limited, personal, non-transferable, non-exclusive, non-sublicensable, fully revocable and temporary license to use and remotely access (i.e., on a SaaS basis) the Company’s proprietary software product known as Browsi Insights (“Product”), during the Trial Period (as defined below), for the sole purpose of internally evaluating the Product in order to determine whether to enter into a definitive commercial agreement (collectively, the “License”).
2. Restrictions of Use. Unless otherwise expressly permitted under these Terms and without the Company’s prior written consent, Evaluator may not, directly or indirectly: (i) copy, modify, create derivative works of, or distribute any part of the Product (including by incorporation into its products); (ii) sell, license (or sublicense), lease, assign, transfer, pledge, or share Evaluator’s rights under these Terms with any third party; (iii) use any open source or copyleft Product in a manner that would require disclosure of the Product source code to any third party; (iv) disclose any testing or benchmarking results to any third party; (v) disassemble, decompile, reverse engineer, or attempt to discover the Product’s source code or underlying algorithms; (vi) use the Product to violate or infringe any third-party rights (including privacy, publicity, or intellectual property rights); (vii) remove or alter any trademarks or proprietary notices; (viii) circumvent, disable, or interfere with security-related features or use limitations; (ix) export, make available, or use the Product in violation of applicable law (including export control laws); or (x) transmit malicious code or other unlawful material in connection with the Product.
3. Trial Period. These Terms shall commence on the Effective Date and shall remain in effect for a period of 14 days, unless earlier terminated in accordance with Section Error! Reference source not found. below (“Trial Period”). The Trial Period may be extended by mutual written agreement of the parties.
4. Fees. The fees for the Trial Period shall be free of charge.
5. Confidentiality. All information disclosed by either Party (“Disclosing Party”) to the other Party (“Receiving Party”), prior to or during the term of these Terms, whether in writing, orally or in any other form which is not in the public domain (“Confidential Information”), shall be held in absolute confidence, and Receiving Party shall take all reasonable and necessary safeguards (affording the Confidential Information at least the same level of protection that it affords its own information of similar importance but in no event less than reasonable case) to prevent the disclosure of such Confidential Information to third parties. In addition, Receiving Party will limit its disclosure of the Confidential Information to employees and consultants with a “need to know” and only in the context of such employees’ and consultants’ fulfillment of their duties under these Terms, and further provided that such employees and consultants are engaged in a confidentiality agreement with the Receiving Party with terms and conditions similar to the confidentiality terms under these Terms and that Receiving Party shall remain liable for any breach of the terms herein by any of its employees and consultants. The provisions of this paragraph shall survive termination or expiration of these Terms for a period of 5 years. It is agreed that the following shall not be considered Confidential Information: (i) information that is already known to the Receiving Party at the time of disclosure, as such may be evidenced in the Receiving Party’s written records; (ii) information that is or becomes known to the general public through no act or omission of the Receiving Party in breach of these Terms; (iii) information that is disclosed to the Receiving Party by a third party who is not, to the knowledge of the Receiving Party, in breach of an obligation of confidentiality; or (iv) information that was or is independently developed by the Receiving Party without use of any of the Confidential Information, as such may be evidenced in the Receiving Party’s written records. It is further agreed that the Receiving Party may disclose any information pursuant to a court order, provided the Receiving Party notifies the Disclosing Party of such order and uses reasonable efforts to limit such disclosure only to the extent required. For avoidance of doubt, the Product constitute Confidential Information of Company. The Receiving Party agrees that the wrongful disclosure of Confidential Information may cause irreparable injury that is inadequately compensable in monetary damages. Accordingly, the Disclosing Party may seek injunctive relief in any court of competent jurisdiction for the breach or threatened breach of confidentiality, in addition to any other remedies in law or equity and without the necessity of proving actual damages or posting bond.
6. Ownership.
6.1 Title. The parties agree that as between them, Company retains all right, title and interest in and to the Product and the Confidential Information, including all intellectual property rights under patent laws, copyright laws, international copyright treaties and trade secret laws, as well as other intellectual property laws. Company claims and reserves all rights and benefits afforded under applicable law in all software programs and other materials that constitute the Product and in the Company’s Confidential Information. The parties further agree that: (i) all derivatives, fixes, inventions, improvements, modifications and Feedback (as defined below) to or in connection with the Product, made during, after, in connection with or as a result of the License, are the exclusive property of Company; and (ii) all rights, title and interest in and to any derivative, fix, invention, improvement or modification to the Product will be wholly owned by Company.
6.2 Evaluator Data. As between the parties, Evaluator is, and shall be, the sole and exclusive owner of all data and information inputted or uploaded to the Product by Evaluator.
6.3 Feedback. It is understood that Evaluator may, at its sole discretion, provide Company with suggestions and/or comments with respect to the Product (“Feedback”). Evaluator represents that it is free to do so and that it shall not knowingly provide Company with Feedback that infringes upon third parties’ intellectual property rights. Evaluator further acknowledges that notwithstanding anything herein to the contrary, any and all rights, including intellectual property rights in such Feedback shall belong exclusively to Company and that such shall be considered Company’s Confidential Information. It is further understood that use of Feedback, if any, may be made by Company at its sole discretion, and that Company, in no way, shall be obliged to make use of any kind of the Feedback or part thereof.
7. Third Party Components. The Product may use or include third party open source software, files, libraries or components that may be distributed to Evaluator and are subject to third party open source license terms which can be provided upon request. If there is a conflict between any open source license and the terms of these Terms, then the open source license terms shall prevail but solely in connection with the related third party open source software. Company makes no warranty or indemnity hereunder with respect to any third party open source software.
8. Termination. Company may terminate these Terms at any time upon prior written notice to the other party. In addition, Company may terminate these Terms immediately if Evaluator is in breach of any of the terms of these Terms. Following termination or expiration of the Terms, or upon written request of Company: (a) each Party shall promptly return or destroy all Confidential Information received from the other party, and all copes thereof, (b) the License shall automatically terminate; and (c) and Evaluator shall: (i) immediately cease access to and use of the Product; (ii) return the Product and all copies thereof, as well as it related documentation in Evaluator’s possession or control to Company; and (iii) erase or otherwise destroy all copies of the Product in its possession, which are fixed or resident in the memory or hard disks of its devices. Upon termination or expiration of these Terms, the provisions of Sections 5 -6 and 8-10, shall perpetually survive, or shall survive according to their terms.
9. No Warranty; Limitation of Liability.
9.1 THE PRODUCT IS PROVIDED “AS IS” AND WITHOUT EXPRESS, IMPLIED OR STATUTORY WARRANTY. IN NO EVENT SHALL COMPANY BE LIABLE FOR WARRANTY OF ANY KIND, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. Evaluator acknowledges that the use of the Product is done entirely at Evaluator’s own risk. Evaluator shall have the sole responsibility for adequate protection of its data and other property used in connection with the Product and shall not make any claim against Company resulting from its use of the Product.
9.2 IN NO EVENT SHALL COMPANY BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING WITHOUT LIMITATION, ANY LOST PROFITS, LOST SAVINGS OR OTHER INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR ANY CLAIM BY ANY OTHER PARTY, HOWEVER CAUSED, BASED ON ANY THEORY OF LIABILITY AND WHETHER OR NOT COMPANY OR ANY RELATED PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, ARISING IN ANY WAY OUT OF THESE TERMS, THE PRODUCT, OR EVALUATOR’S USE OF THE PRODUCT. IN ANY EVENT, COMPANY’S AGGREGATE LIABILITY UNDER THESE TERMS SHALL NOT EXCEED THE AMOUNT ACTUALLY PAID BY EVALUATOR TO COMPANY UNDER THESE TERMS, AND IF NONE – US $100.
10. Miscellaneous.
10.1 Evaluator agrees: (i) that Company shall be entitled to refer to Evaluator as a trial user of Company in its marketing materials, including, without limitation, in its website and in press releases and that Company may use Evaluator’s logo/s and trademark/s in size and form as provided by Evaluator to Company.
10.2 All notices or reports under these Terms must be delivered by personal delivery, express courier requiring proof of delivery, certified or registered mail (return receipt requested), facsimile, or email, and will be effective: (a) if mailed, 5 business days after mailing; (b) if delivered by messenger or express courier, upon delivery; and (c) if sent by facsimile or email, upon transmission and electronic confirmation of receipt (or, if sent or received on a non-business day, on the first business day after transmission and confirmation).
10.3 These Terms shall be governed by and construed in accordance with the laws of the State of Israel, without regard to conflict of law principles. Any action arising out of or in any way connected with these Terms shall be brought exclusively to the applicable courts of Tel-Aviv-Yafo, Israel.
10.4 Each party and its employees and agents are independent contractors in relation to the other party with respect to all matters arising under these Terms. Nothing herein shall be deemed to establish a partnership, joint venture, association or employment relationship between the parties. These Terms may not be assigned or otherwise transferred by Evaluator without Company’s prior written consent. These Terms set forth the entire understanding between the parties with respect to the subject matter herein and supersede all prior and contemporaneous written agreements and discussions concerning the subject matter of these Terms. Company may modify these Terms from time to time by posting the updated Terms (or an updated version of these Terms of Use) within the Product and/or on Company’s website, or by otherwise providing notice to Evaluator (including by email or in-product notice). Evaluator’s continued access to or use of the Product after the effective date of any changes constitutes Evaluator’s acceptance of the revised Terms.